Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs

Lecanemab 10 mg/kgOngoingRecruitingPhase 4Open NCT07604896 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT07604896 · Trial Tracker · ComplyRx